Biomarker Panel For Prediction Of Recurrent Colorectal Cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110059464A1
SERIAL NO

12936231

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a biomarker panel predictive of whether colorectal cancer is likely to recur or metastasize in an afflicted patient. By identifying the likelihood of recurrence, a treatment provider may determine in advance those patients who would benefit from certain types of treatment. The present invention further provide methods of identifying gene and protein expression profiles associated with the likelihood of recurrence/metastasis of colorectal cancer in a patient sample.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NUCLEA BIOTECHNOLOGIES INC105 SOUTH STREET PITTSFIELD MA 01201

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Muraca, Patrick J Pittsfield, US 48 438

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation